Results 131 to 140 of about 36,666,975 (299)
Anticoagulation Treatment Response Among Phenotypic ESUS Clusters: Evidence From CASPR
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective To evaluate treatment effect heterogeneity across phenotypic clusters of patients with cryptogenic embolic stroke using causal inference methods. Methods From a retrospective, multicenter cohort of patients with cryptogenic embolic stroke, we estimated the treatment effect of anticoagulation versus antiplatelet therapy in patients ...
Elena Badillo Goicoechea +53 more
wiley +1 more source
Glucagon‐Like Peptide‐1 Receptor Agonists in Multiple Sclerosis: A Topical Narrative Review
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT The glucagon‐like peptide‐1 (GLP‐1) receptor agonists (RAs) are a relatively new class of drugs that were initially approved by the US Food and Drug Administration to improve glycemic control in patients with type 2 diabetes mellitus and, subsequently, weight reduction in patients with obesity.
Audrey Y. Chang, Farrah J. Mateen
wiley +1 more source
Therapy of Type 1 Diabetes [PDF]
Experimental and Clinical Endocrinology & Diabetes, 2019 Thomas, Haak +8 more
openaire +3 more sources
Shifting the paradigm of type 1 diabetes: a narrative review of disease-modifying therapies
Frontiers in EndocrinologyA new diagnosis of type 1 diabetes (T1D) may be accompanied by numerous lifelong financial, emotional, and physical challenges, thus advancements in therapies that can delay the onset of clinical disease are crucial.
Alexander J. O’Donovan +3 more
doaj +1 more source
Arthritis Care &Research, EarlyView.Objective This research article aims to describe the prevalence, associations, and health‐related quality of life (HRQoL) impact of mucocutaneous features of systemic lupus erythematosus (SLE). Methods Data from the Asia‐Pacific Lupus Collaboration cohort were analyzed (2013–2021).
Amanda M. Saracino +42 more
wiley +1 more source
The Pathogenesis of Type 1 Diabetes
Cold Spring Harbor Perspectives in MedicineType 1 diabetes (T1D) is a chronic autoimmune disease with a metabolic outcome. Studies over the past decades, have identified the contributions of genetics, environmental factors, and disorders of innate and adaptive immunity that collectively cause β-cell killing.
Herold, Kevan C., Krischer, Jeffrey P.
openaire +2 more sources
Skin autofluorescence in diabetes mellitus [PDF]
, 2008 AGEs ofwel advanced glycation endproducts zijn onomkeerbaar versuikerde stoffen, die voornamelijk aan eiwitten zijn gekoppeld, en die bij ieder mens stapelen. Bij iemand met diabetes mellitus gaat dit proces echter versneld.
Lutgers, Helen Lucia +2 more
core +14 more sources
Associations between daily dietary carbohydrate intake and TIR in adults with type 1 diabetes
Frontiers in NutritionObjectiveTo assess the association between daily carbohydrate (CHO) intake and glycemic control in adults with type 1 diabetes (T1D).MethodsPatients with T1D who received continuous glucose monitoring (CGM) to manage their blood glucose levels were ...
Yunying Cai +5 more
doaj +1 more source
Arthritis Care &Research, EarlyView.Objective This study aimed to characterize cannabis product choices (cannabinoid content and formulation) among patients with rheumatologic conditions and their associations with patient factors, patient‐reported perceived side effects, and positive impacts.
Susan Zhang +10 more
wiley +1 more source
NPY Levels In Type 1 Diabetic Men of Different Duration. [PDF]
, 2011 Background: The aim of the present study was to evaluate whether the different duration of type 1 diabetes mellitus influences basal NPY secretion. Design: The NPY concentrations were measured in sixty-eight men with insulin-dependent diabetes mellitus ...
Lavinia Volpi +10 more
core